These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9784861)

  • 21. Osteocalcin is angiogenic in vivo.
    Cantatore FP; Crivellato E; Nico B; Ribatti D
    Cell Biol Int; 2005 Jul; 29(7):583-5. PubMed ID: 15979904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL.
    Bruncko M; Oost TK; Belli BA; Ding H; Joseph MK; Kunzer A; Martineau D; McClellan WJ; Mitten M; Ng SC; Nimmer PM; Oltersdorf T; Park CM; Petros AM; Shoemaker AR; Song X; Wang X; Wendt MD; Zhang H; Fesik SW; Rosenberg SH; Elmore SW
    J Med Chem; 2007 Feb; 50(4):641-62. PubMed ID: 17256834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel small molecule alpha v integrin antagonists: comparative anti-cancer efficacy with known angiogenesis inhibitors.
    Kerr JS; Wexler RS; Mousa SA; Robinson CS; Wexler EJ; Mohamed S; Voss ME; Devenny JJ; Czerniak PM; Gudzelak A; Slee AM
    Anticancer Res; 1999; 19(2A):959-68. PubMed ID: 10368639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basic fibroblast growth factor-induced angiogenesis in the chick embryo chorioallantoic membrane: an electron microscopy study.
    Ribatti D; Nico B; Bertossi M; Roncali L; Presta M
    Microvasc Res; 1997 Mar; 53(2):187-90. PubMed ID: 9143552
    [No Abstract]   [Full Text] [Related]  

  • 25. alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro.
    Nisato RE; Tille JC; Jonczyk A; Goodman SL; Pepper MS
    Angiogenesis; 2003; 6(2):105-19. PubMed ID: 14739617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and SAR of N-substituted dibenzazepinone derivatives as novel potent and selective alpha(V)beta(3) antagonists.
    Kling A; Backfisch G; Delzer J; Geneste H; Graef C; Holzenkamp U; Hornberger W; Lange UE; Lauterbach A; Mack H; Seitz W; Subkowski T
    Bioorg Med Chem Lett; 2002 Feb; 12(3):441-6. PubMed ID: 11814816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic rats.
    Santulli RJ; Kinney WA; Ghosh S; Decorte BL; Liu L; Tuman RW; Zhou Z; Huebert N; Bursell SE; Clermont AC; Grant MB; Shaw LC; Mousa SA; Galemmo RA; Johnson DL; Maryanoff BE; Damiano BP
    J Pharmacol Exp Ther; 2008 Mar; 324(3):894-901. PubMed ID: 18083913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eptifibatide and 7E3, but not tirofiban, inhibit alpha(v)beta(3) integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin.
    Lele M; Sajid M; Wajih N; Stouffer GA
    Circulation; 2001 Jul; 104(5):582-7. PubMed ID: 11479257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel radiological approach for the experimental study of angiogenesis: angiography of the chick embryo and its chorioallantoic membrane.
    Siamblis D; Karnabatidis D; Hatjikondi O; Kalogeropoulou C; Kardamakis D; Dimopoulos J
    Eur J Radiol; 1996 Feb; 21(3):220-4. PubMed ID: 8777914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis.
    Lark MW; Stroup GB; Hwang SM; James IE; Rieman DJ; Drake FH; Bradbeer JN; Mathur A; Erhard KF; Newlander KA; Ross ST; Salyers KL; Smith BR; Miller WH; Huffman WF; Gowen M
    J Pharmacol Exp Ther; 1999 Nov; 291(2):612-7. PubMed ID: 10525079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of angiogenesis by humulone, a bitter acid from beer hop.
    Shimamura M; Hazato T; Ashino H; Yamamoto Y; Iwasaki E; Tobe H; Yamamoto K; Yamamoto S
    Biochem Biophys Res Commun; 2001 Nov; 289(1):220-4. PubMed ID: 11708802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1.
    Chandrasekaran L; He CZ; Al-Barazi H; Krutzsch HC; Iruela-Arispe ML; Roberts DD
    Mol Biol Cell; 2000 Sep; 11(9):2885-900. PubMed ID: 10982388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy.
    Harris TD; Kalogeropoulos S; Nguyen T; Liu S; Bartis J; Ellars C; Edwards S; Onthank D; Silva P; Yalamanchili P; Robinson S; Lazewatsky J; Barrett J; Bozarth J
    Cancer Biother Radiopharm; 2003 Aug; 18(4):627-41. PubMed ID: 14503959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro.
    Collin-Osdoby P; Rothe L; Bekker S; Anderson F; Huang Y; Osdoby P
    J Bone Miner Res; 2002 Oct; 17(10):1859-71. PubMed ID: 12369790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel bicyclic oxazolone derivatives as anti-angiogenic agents.
    Perron-Sierra FM; Pierré A; Burbridge M; Guilbaud N
    Bioorg Med Chem Lett; 2002 Jun; 12(11):1463-6. PubMed ID: 12031320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substituted benzocyloheptenes as potent and selective alpha(v) integrin antagonists.
    Perron-Sierra F; Saint Dizier D; Bertrand M; Genton A; Tucker GC; Casara P
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3291-6. PubMed ID: 12392735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide.
    Meissner RS; Perkins JJ; Duong LT; Hartman GD; Hoffman WF; Huff JR; Ihle NC; Leu CT; Nagy RM; Naylor-Olsen A; Rodan GA; Rodan SB; Whitman DB; Wesolowski GA; Duggan ME
    Bioorg Med Chem Lett; 2002 Jan; 12(1):25-9. PubMed ID: 11738566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trapidil inhibits endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane and in the rat cornea.
    Benelli U; Lepri A; Nardi M; Danesi R; Del Tacca M
    J Ocul Pharmacol Ther; 1995; 11(2):157-66. PubMed ID: 8564636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of selective or combined inhibition of integrins alpha(IIb)beta(3) and alpha(v)beta(3) on thrombosis and neointima after oversized porcine coronary angioplasty.
    Chico TJ; Chamberlain J; Gunn J; Arnold N; Bullens SL; Gadek TR; Francis SE; Bunting S; Horton M; Shepherd L; Lipari MT; Quan C; Knolle J; Stilz HU; Peyman A; Crossman DC
    Circulation; 2001 Feb; 103(8):1135-41. PubMed ID: 11222478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo models to study chemokine regulation of angiogenesis.
    Bernardini G; Ribatti D; Spinetti G; Morbidelli L; Ziche M; Santoni A; Capogrossi MC; Napolitano M
    Methods Mol Biol; 2004; 239():223-32. PubMed ID: 14573922
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.